The platform is set to transform patient care, enhance clinical outcomes, and streamline operations across Burjeel’s network ...

Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress: Indianapolis Monday, February 10, 20 ...

The European Commission (EC) has approved sugemalimab in combination with platinum-based chemotherapy for the first-line treatment of patients with metastatic NSCLC with no sensitizing EGFR mutations, ...

Two leading US-based autism centres have joined Blinklab’s autism diagnostic registrational trial. ... Read More The post ...

Health New Zealand’s new strategy to “fail early, fail often, succeed over time” when it comes to crucial data and digital ...

A dairy worker in Nevada has reportedly been infected by the killer variant of H5N1 bird flu; analysis shows changes in new ...

Melinda Bachini is the Chief Patient Officer at the Cholangiocarcinoma Foundation and a 15-year survivor of ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

The FDA made strides in R/R T-cell lymphoma and breast cancer. An AI tool aids pathologists and other positive updates in gastric cancer and NSCLC.